Get App

Marksans Pharma gets UK MHRA nod for diarrhea medication

Drug firm Marksans Pharma on Thursday said its subsidiary has received market authorisation from the UK health regulator for its anti-diarrhoea medication Loperamide capsules.
  • Published On Dec 10, 2021 at 04:20 PM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
Drug firm Marksans Pharma on Thursday said its subsidiary has received market authorisation from the UK health regulator for its anti-diarrhoea medication Loperamide capsules. The UK MHRA has granted market authorisation to the company's wholly-owned subsidiary Relonchem Ltd for Loperamide hard capsules (2mg), Marksans Pharma said in a regulatory filing.

Marksans Pharma said it will manufacture the product at its Goa-based oral dosage facility.
  • Published On Dec 10, 2021 at 04:20 PM IST
Be the first one to comment.
Comment Now

COMMENTS

Comment Now Read Comment (1)

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App